BACKGROUND:Selective serotonin reuptake inhibitors (SSRIs) are often prescribed in patients with postural tachycardia syndrome (POTS), and act at synaptic terminals to increase monoamine neurotransmitters. We hypothesized that they act to increase blood pressure and attenuate reflex tachycardia, thereby improving symptoms. Acute hemodynamic profiles after SSRI administration in POTS patients have not previously been reported. METHODS:Patients with POTS (n=39; F=37, 39 ±9 years) underwent a randomized crossover trial with sertraline 50mg and placebo. Heart rate, systolic, diastolic, and mean blood pressure were measured with the patient seated and standing for 10 min prior to drug or placebo administration, and then hourly for 4 h. The primary endpoint was standing heart rate at 4 h. RESULTS: At 4 h, standing heart rate and systolic blood pressure were not significantly different between sertraline and placebo. Seated systolic (106±12 mmHg vs. 101±8 mmHg; p=0.041), diastolic (72±8 mmHg vs. 69±8 mmHg; p=0.022), and mean blood pressure (86±9 mmHg vs. 81±9 mmHg; p=0.007) were significantly higher after sertraline administration than placebo. At 4 h, symptoms were worse with sertraline than placebo. CONCLUSIONS:Sertraline had a modest pressor effect in POTS patients, but this did not translate into a reduced heart rate or improved symptoms.
RCT Entities:
BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are often prescribed in patients with postural tachycardia syndrome (POTS), and act at synaptic terminals to increase monoamine neurotransmitters. We hypothesized that they act to increase blood pressure and attenuate reflex tachycardia, thereby improving symptoms. Acute hemodynamic profiles after SSRI administration in POTS patients have not previously been reported. METHODS:Patients with POTS (n=39; F=37, 39 ±9 years) underwent a randomized crossover trial with sertraline 50mg and placebo. Heart rate, systolic, diastolic, and mean blood pressure were measured with the patient seated and standing for 10 min prior to drug or placebo administration, and then hourly for 4 h. The primary endpoint was standing heart rate at 4 h. RESULTS: At 4 h, standing heart rate and systolic blood pressure were not significantly different between sertraline and placebo. Seated systolic (106±12 mmHg vs. 101±8 mmHg; p=0.041), diastolic (72±8 mmHg vs. 69±8 mmHg; p=0.022), and mean blood pressure (86±9 mmHg vs. 81±9 mmHg; p=0.007) were significantly higher after sertraline administration than placebo. At 4 h, symptoms were worse with sertraline than placebo. CONCLUSIONS:Sertraline had a modest pressor effect in POTS patients, but this did not translate into a reduced heart rate or improved symptoms.
Authors: Jordan A Brewster; Emily M Garland; Italo Biaggioni; Bonnie K Black; John F Ling; Cyndya A Shibao; David Robertson; Satish R Raj Journal: Clin Sci (Lond) Date: 2012-01 Impact factor: 6.124
Authors: K A Yonkers; U Halbreich; E Freeman; C Brown; J Endicott; E Frank; B Parry; T Pearlstein; S Severino; A Stout; A Stone; W Harrison Journal: JAMA Date: 1997-09-24 Impact factor: 56.272
Authors: M H Kronig; J Apter; G Asnis; A Bystritsky; G Curtis; J Ferguson; R Landbloom; D Munjack; R Riesenberg; D Robinson; P Roy-Byrne; K Phillips; I J Du Pont Journal: J Clin Psychopharmacol Date: 1999-04 Impact factor: 3.153
Authors: M B Keller; J H Kocsis; M E Thase; A J Gelenberg; A J Rush; L Koran; A Schatzberg; J Russell; R Hirschfeld; D Klein; J P McCullough; J A Fawcett; S Kornstein; L LaVange; W Harrison Journal: JAMA Date: 1998-11-18 Impact factor: 56.272
Authors: Andréia Zavaloni Scalco; Maria Urbana Pinto Brandão Rondon; Ivani Credidio Trombetta; Mateus Camaroti Laterza; João Batista Costa Carvalho Azul; Eleanor Maria Pullenayegum; Mônica Zavaloni Scalco; Fátima Helena Sert Kuniyoshi; Maurício Wajngarten; Carlos Eduardo Negrão; Francisco Lotufo-Neto Journal: J Hypertens Date: 2009-12 Impact factor: 4.844
Authors: Samuel T Coffin; Bonnie K Black; Italo Biaggioni; Sachin Y Paranjape; Carlos Orozco; Phillip W Black; William D Dupont; David Robertson; Satish R Raj Journal: Heart Rhythm Date: 2012-05-03 Impact factor: 6.343
Authors: D T Wong; F P Bymaster; L R Reid; D A Mayle; J H Krushinski; D W Robertson Journal: Neuropsychopharmacology Date: 1993-06 Impact factor: 7.853
Authors: Julian M Stewart; Jeffrey R Boris; Gisela Chelimsky; Phillip R Fischer; John E Fortunato; Blair P Grubb; Geoffrey L Heyer; Imad T Jarjour; Marvin S Medow; Mohammed T Numan; Paolo T Pianosi; Wolfgang Singer; Sally Tarbell; Thomas C Chelimsky Journal: Pediatrics Date: 2017-12-08 Impact factor: 7.124
Authors: Emily M Garland; Alfredo Gamboa; Victor C Nwazue; Jorge E Celedonio; Sachin Y Paranjape; Bonnie K Black; Luis E Okamoto; Cyndya A Shibao; Italo Biaggioni; David Robertson; André Diedrich; William D Dupont; Satish R Raj Journal: J Am Coll Cardiol Date: 2021-05-04 Impact factor: 24.094
Authors: Brian Olshansky; David Cannom; Artur Fedorowski; Julian Stewart; Christopher Gibbons; Richard Sutton; Win-Kuang Shen; James Muldowney; Tae Hwan Chung; Suzy Feigofsky; Hemal Nayak; Hugh Calkins; David G Benditt Journal: Prog Cardiovasc Dis Date: 2020-03-25 Impact factor: 11.278